Livzon Pharmaceutical Group Inc. financial reports, Livzon Pharmaceutical Group Inc. annual revenue in 2024. When does Livzon Pharmaceutical Group Inc. report revenue?
Livzon Pharmaceutical Group Inc. total revenue, net income and dynamics of changes in Euro today
Livzon Pharmaceutical Group Inc. current income and income for the latest reporting periods. The dynamics of Livzon Pharmaceutical Group Inc. net income grew by 226 288 174 € for the last reporting period. These are the main financial indicators of Livzon Pharmaceutical Group Inc.. Livzon Pharmaceutical Group Inc. online financial report chart. The financial report on the chart of Livzon Pharmaceutical Group Inc. allows you to clearly see the dynamics of fixed assets. The value of "net income" Livzon Pharmaceutical Group Inc. on the graph is displayed in blue.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
3 078 981 671.38 €
+28.47 % ↑
477 637 291.10 €
+32.3 % ↑
31/12/2020
2 385 087 310.57 €
+28.51 % ↑
269 644 515.97 €
+106.49 % ↑
30/09/2020
2 601 459 095.71 €
+20.14 % ↑
383 105 282.63 €
+38.52 % ↑
30/06/2020
2 381 069 251.86 €
+11.11 % ↑
556 439 056.55 €
+74.88 % ↑
30/09/2019
2 165 360 221.67 €
-
276 562 857.83 €
-
30/06/2019
2 143 011 319.21 €
-
318 184 821.04 €
-
31/03/2019
2 396 730 820.60 €
-
361 019 020.84 €
-
31/12/2018
1 855 965 857.11 €
-
130 583 838.12 €
-
Show:
to
Livzon Pharmaceutical Group Inc. financial report charts
Dates of Livzon Pharmaceutical Group Inc. finance reports: 31/12/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Livzon Pharmaceutical Group Inc. for today is 31/03/2021. Gross profit Livzon Pharmaceutical Group Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Livzon Pharmaceutical Group Inc. is 2 226 940 505 €
Livzon Pharmaceutical Group Inc. quarterly report dates
Cost of revenue Livzon Pharmaceutical Group Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Livzon Pharmaceutical Group Inc. is 1 122 873 640 € Total revenue Livzon Pharmaceutical Group Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Livzon Pharmaceutical Group Inc. is 3 349 814 145 € Operating income Livzon Pharmaceutical Group Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Livzon Pharmaceutical Group Inc. is 647 957 925 €
Net income Livzon Pharmaceutical Group Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Livzon Pharmaceutical Group Inc. is 519 651 081 € Current assets Livzon Pharmaceutical Group Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Livzon Pharmaceutical Group Inc. is 15 408 820 931 € Total assets Livzon Pharmaceutical Group Inc. refers to the total amount of assets owned by a person or entity. Total assets Livzon Pharmaceutical Group Inc. is 21 358 886 900 €
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 046 892 365.17 €
1 410 259 557.59 €
1 728 844 355.02 €
1 584 366 968.12 €
1 392 678 133.60 €
1 376 099 989.40 €
1 557 739 130.12 €
1 068 817 303.03 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 032 089 306.21 €
974 827 752.99 €
872 614 740.69 €
796 702 283.74 €
772 682 088.08 €
766 911 329.81 €
838 991 690.48 €
787 148 554.08 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
3 078 981 671.38 €
2 385 087 310.57 €
2 601 459 095.71 €
2 381 069 251.86 €
2 165 360 221.67 €
2 143 011 319.21 €
2 396 730 820.60 €
1 855 965 857.11 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
595 570 526.76 €
217 246 059.48 €
536 846 398.17 €
664 746 891.83 €
371 704 631.34 €
304 243 984.75 €
413 261 779.76 €
53 141 977.15 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
477 637 291.10 €
269 644 515.97 €
383 105 282.63 €
556 439 056.55 €
276 562 857.83 €
318 184 821.04 €
361 019 020.84 €
130 583 838.12 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
212 769 778.75 €
275 605 043.79 €
255 350 436.55 €
158 598 944.62 €
177 959 694.11 €
137 742 652.60 €
127 395 054 €
182 555 902.76 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 483 411 144.61 €
2 167 841 251.10 €
2 064 612 697.54 €
1 716 322 360.03 €
1 793 655 590.34 €
1 838 767 334.46 €
1 983 469 040.84 €
1 802 823 879.96 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
14 163 017 758.73 €
13 444 735 162.65 €
12 733 988 813.46 €
10 951 959 204.95 €
10 386 929 890.15 €
10 929 048 063.03 €
10 482 655 933.30 €
11 463 389 016.39 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
19 632 020 894.14 €
18 926 048 326.03 €
17 758 171 610.68 €
15 857 013 874.26 €
15 010 903 643.70 €
15 513 095 967.31 €
15 112 977 768.75 €
16 027 537 351.66 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
9 366 835 232.24 €
9 148 987 072.53 €
8 306 002 493.35 €
6 692 955 796.07 €
6 634 020 422.90 €
7 139 941 303.30 €
6 735 001 125.28 €
7 893 593 352.06 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
3 732 099 093.21 €
4 576 969 224.97 €
3 722 078 072.28 €
4 935 447 610.43 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
4 036 175 754.05 €
4 874 637 140.01 €
4 011 452 747.80 €
5 227 637 996.27 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
26.89 %
31.42 %
26.54 %
32.62 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
11 506 387 824.01 €
11 128 371 391.47 €
10 662 213 895.98 €
10 199 425 632.15 €
9 982 217 600.66 €
9 681 828 920.74 €
10 138 447 389.28 €
9 790 765 089.71 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
431 870 097.43 €
438 922 361.29 €
441 957 448.82 €
589 423 019.02 €
Last revenue report of Livzon Pharmaceutical Group Inc. was 31/03/2021. According to last financial report total revenue in Livzon Pharmaceutical Group Inc. was 3 078 981 671.38 Euro and changed by +28.47% since last year. Net income in Livzon Pharmaceutical Group Inc. was 477 637 291.10 € in last quartal, net income changes to +32.3%.
Current cash Livzon Pharmaceutical Group Inc. - the sum of all of the cash a company has on the date of report. Current cash Livzon Pharmaceutical Group Inc. is 10 190 758 018 €
Livzon Pharmaceutical Group Inc. stocks data
LP6.F stock price
Livzon Pharmaceutical Group Inc. stock price today, LP6.F stock quote.
